Congratulations to Prof. Ofer Mandelboim and Dr. Pini Tsukerman as their company, Nectin Therapeutics Ltd., received FDA approval to initiate clinical trials

Congratulations to Prof. Ofer Mandelboim and Dr. Pini Tsukerman as their company, Nectin Therapeutics Ltd., received FDA approval to initiate clinical trials using their monoclonal antibody, NTX1088. The clinical trials will assess the immune checkpoint modulation profile and safety of NTX1088.
To Nectin web

Scroll to top